MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity
Authors
Keywords
-
Journal
ONCOGENE
Volume 35, Issue 4, Pages 448-458
Publisher
Springer Nature
Online
2015-04-14
DOI
10.1038/onc.2015.96
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Oncogenic MicroRNA-21 Inhibits the Tumor Suppressive Activity of FBXO11 to Promote Tumorigenesis
- (2015) Chuan He Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial
- (2014) H. Bonnefoi et al. ANNALS OF ONCOLOGY
- PKD1 Phosphorylation-Dependent Degradation of SNAIL by SCF-FBXO11 Regulates Epithelial-Mesenchymal Transition and Metastasis
- (2014) Hanqiu Zheng et al. CANCER CELL
- Overactivated Neddylation Pathway as a Therapeutic Target in Lung Cancer
- (2014) Lihui Li et al. JNCI-Journal of the National Cancer Institute
- Contribution of p53 to Metastasis
- (2014) E. Powell et al. Cancer Discovery
- miRNA Dysregulation in Breast Cancer
- (2013) L. Mulrane et al. CANCER RESEARCH
- Dynamic Methylation of Numb by Set8 Regulates Its Binding to p53 and Apoptosis
- (2013) Gurpreet Kaur Dhami et al. MOLECULAR CELL
- CRL1-FBXO11 Promotes Cdt2 Ubiquitylation and Degradation and Regulates Pr-Set7/Set8-Mediated Cellular Migration
- (2013) Tarek Abbas et al. MOLECULAR CELL
- MicroRNAs and other non-coding RNAs as targets for anticancer drug development
- (2013) Hui Ling et al. NATURE REVIEWS DRUG DISCOVERY
- Mechanisms and function of substrate recruitment by F-box proteins
- (2013) Jeffrey R. Skaar et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets
- (2013) J. M. Balko et al. Cancer Discovery
- The rebel angel: mutant p53 as the driving oncogene in breast cancer
- (2012) D. Walerych et al. CARCINOGENESIS
- Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27
- (2012) Eleftherios P. Mamounas et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer
- (2012) Hongjiang Wang et al. PLoS One
- The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer
- (2011) Ji-Yu Li et al. BREAST CANCER RESEARCH AND TREATMENT
- Estrogen receptor-related genes as an important panel of predictors for breast cancer response to neoadjuvant chemotherapy
- (2011) Yizuo Chen et al. CANCER LETTERS
- Do predictive signatures really predict response to cancer chemotherapy?
- (2011) Piet Borst et al. CELL CYCLE
- SET8 promotes epithelial-mesenchymal transition and confers TWIST dual transcriptional activities
- (2011) Fen Yang et al. EMBO JOURNAL
- A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer
- (2011) Christos Hatzis JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Docetaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy for Patients with Primary Breast Cancer
- (2011) H. Iwata et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas
- (2011) Shanshan Duan et al. NATURE
- Challenges translating breast cancer gene signatures into the clinic
- (2011) Britta Weigelt et al. Nature Reviews Clinical Oncology
- Weekly paclitaxel plus carboplatin is an effective nonanthracycline-containing regimen as neoadjuvant chemotherapy for breast cancer
- (2010) X. S. Chen et al. ANNALS OF ONCOLOGY
- Prospective Comparison of Clinical and Genomic Multivariate Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2010) J. K. Lee et al. CLINICAL CANCER RESEARCH
- Evaluation of a 30-Gene Paclitaxel, Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy Response Predictor in a Multicenter Randomized Trial in Breast Cancer
- (2010) A. Tabchy et al. CLINICAL CANCER RESEARCH
- MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression
- (2010) Ming Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ki67 in breast cancer: prognostic and predictive potential
- (2010) Rinat Yerushalmi et al. LANCET ONCOLOGY
- CORNA: testing gene lists for regulation by microRNAs
- (2009) X. Wu et al. BIOINFORMATICS
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- MicroRNA-328 Negatively Regulates the Expression of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Cancer Cells
- (2009) Y.-Z. Pan et al. MOLECULAR PHARMACOLOGY
- Cytoplasmic functions of the tumour suppressor p53
- (2009) Douglas R. Green et al. NATURE
- Loss of 13q is associated with genes involved in cell cycle and proliferation in dedifferentiated hepatocellular carcinoma
- (2008) Britta Skawran et al. MODERN PATHOLOGY
- MicroRNAs modulate the chemosensitivity of tumor cells
- (2008) P. E. Blower et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started